Literature DB >> 2391269

Prevalence and geographic distribution of Fanconi syndrome in Basenjis in the United States.

C H Noonan1, J M Kay.   

Abstract

A survey was conducted to ascertain the prevalence of Fanconi syndrome in Basenjis and to determine in which geographic regions the greatest number of affected dogs resided. A thousand questionnaires were distributed nationally, and 624 (62%) were returned. Through this survey, prevalence, geographic distribution, and breeder involvement were successfully correlated with the overall association of the disease with the Basenji breed. Ten percent (96/959) of all Basenjis involved in the survey had Fanconi syndrome. Half (50%; 48/96) of the Basenjis affected were between 4 and 8 years old. Seventy-six percent (44/58) of owners of Basenjis with Fanconi syndrome were breeding their dogs, and 93% (52/56) had owned other Basenjis before the survey was conducted. Females outnumbered males (3:1) in frequency of the disease. This ratio reflected the higher breeder participation in the survey, rather than being a true gender predilection for the disease.

Entities:  

Mesh:

Year:  1990        PMID: 2391269

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  3 in total

1.  Acquired Fanconi syndrome in a dog exposed to jerky treats in Japan.

Authors:  Masaya Igase; Kenji Baba; Takako Shimokawa Miyama; Shunsuke Noguchi; Takuya Mizuno; Masaru Okuda
Journal:  J Vet Med Sci       Date:  2015-06-11       Impact factor: 1.267

2.  Acquired Fanconi syndrome in two dogs following long-term consumption of pet jerky treats in Japan: case report.

Authors:  Akira Yabuki; Tomoko Iwanaga; Urs Giger; Mariko Sawa; Moeko Kohyama; Osamu Yamato
Journal:  J Vet Med Sci       Date:  2017-04-01       Impact factor: 1.267

3.  Basal glucose excretion in dogs: The impact of feeding, obesity, sex, and age.

Authors:  Florian K Zeugswetter; Ilse Schwendenwein
Journal:  Vet Clin Pathol       Date:  2020-09-24       Impact factor: 1.180

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.